Skip to main content
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2008 Feb;69(1):56–64. doi: 10.1016/j.curtheres.2008.02.004

Endomorphins and ohmefentanyl in the inhibition of immunosuppressant function in rat peritoneal macrophages: An experimental in vitro study

Wei-Yan Li 1,1, Jian-Jun Yang 1, Si-Hai Zhu 1, Hong-Jun Liu 1, Jian-Guo Xu 1
PMCID: PMC3969972  PMID: 24692783

Abstract

Background: The potential immunosuppressant effects of opioids might have clinical implications. The effects of endomorphins (EMs) and ohmefentanyl (OMF) on cultured rat peritoneal macrophages remain unclear.

Objective: The aim of this study was to investigate the immunosuppressant effects of EMs and OMF on cultured rat peritoneal macrophages in vitro.

Methods: Purified rat peritoneal macrophages, from healthy adult male Sprague-Dawley rats, were cultured with EM-1 (EM-1 group), EM-2 (EM-2 group), OMF (OMF group), and saline (saline group). We measured the concentrations of tumor necrosis factor (TNF)-α and interleukin (IL)-β in supernatant when macrophages were cultured with 10−6 mol/L of EM-1, EM-2, OMF, or saline for 0, 6, 12, and 24 hours (time-effect relationship) or with 10−10, 10−9, 10−8, 10−7, and 10−6 mol/L of these substances for 24 hours (concentration-effect relationship). We also determined the phagocytic and bactericidal activities of macrophages using isotope markers when macrophages were cultured with 10−6 mol/L of EM-1, EM-2, OMF, or saline for 24 hours.

Results: Compared with the saline group, TNF-α concentration decreased significantly in the OMF, EM-2, and EM-1 groups at 12 hours (P < 0.05, P < 0.05, and P < 0.01, respectively) and at 24 hours (P < 0.05, P < 0.01, and P < 0.01, respectively). Compared with the saline group, IL-1β concentration decreased signifcantly in the OMF, EM-2, and EM-1 groups at 12 hours (P < 0.05, P < 0.05, and P < 0.01, respectively) and at 24 hours (P < 0.05, P < 0.01, and P < 0.01, respectively). Decreased TNF-α and IL-1β concentrations were observed in the supernatant at 24 hours when cultured with 10−8, 10−7, and 10−6 mol/L in the OMF and EM-2 groups (all, P < 0.05) and in the EM-1 group (all, P < 0.01). Compared with the saline group, macrophage phagocytic activity (all, P < 0.05) and macrophage bactericidal activity (all, P < 0.01) were significantly lower in the 3 experimental groups compared with the saline group.

Conclusion: In this in vitro experiment, EM-1, EM-2, and OMF inhibited the immunosuppressant function of cultured rat peritoneal macrophages, including decreasing TNF-α and IL-1β concentrations and phagocytic and bactericidal activities.

Key Words: endomorphins, ohmefentanyl, macrophage, immunomodulator

Full Text

The Full Text of this article is available as a PDF (441.1 KB).

References

  • 1.Wollemann M, Benyhe S. Non-opioid actions of opioid peptides. Life Sci. 2004;75:257–270. doi: 10.1016/j.lfs.2003.12.005. [DOI] [PubMed] [Google Scholar]
  • 2.Brogden KA, Guthmiller JM, Salzer M, Zasloff M. The nervous system and innate immunity: The neuropeptide connection. Nat Immunol. 2005;6:558–564. doi: 10.1038/ni1209. [DOI] [PubMed] [Google Scholar]
  • 3.Gilmore W, Moloney M, Weiner LP. The role of opioid peptides in immunomodulation. Ann N Y Acad Sci. 1990;597:252–263. doi: 10.1111/j.1749-6632.1990.tb16174.x. [DOI] [PubMed] [Google Scholar]
  • 4.Peterson PK, Molitor TW, Chao CC. The opioid-cytokine connection. J Neuroimmunol. 1998;83:63–69. doi: 10.1016/s0165-5728(97)00222-1. [DOI] [PubMed] [Google Scholar]
  • 5.Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the muopiate receptor. Nature. 1997;386:499–502. doi: 10.1038/386499a0. [DOI] [PubMed] [Google Scholar]
  • 6.Jessop DS, Major GN, Coventry TL. Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues. J Neuroimmunol. 2000;106:53–59. doi: 10.1016/s0165-5728(99)00216-7. [DOI] [PubMed] [Google Scholar]
  • 7.Azuma Y, Ohura K, Wang PL, Shinohara M. Endomorphins 1 and 2 modulate chemotaxis, phagocytosis and superoxide anion production by microglia. J Neuroimmunol. 2001;119:51–56. doi: 10.1016/s0165-5728(01)00363-0. [DOI] [PubMed] [Google Scholar]
  • 8.Gawley RE, Dukh M, Cardona CM. Heptapeptide mimic of ohmefentanyl binding in the discontinuous mu-opioid receptor. Org Lett. 2005;7:2953–2956. doi: 10.1021/ol0509179. [DOI] [PubMed] [Google Scholar]
  • 9.Wang ZY, Wang CQ, Yang JJ. Which has the least immunity depression during post-operative analgesia∔orphine, tramadol, or tramadd with lornoxicam? Clin Chim Acta. 2006;369:40–45. doi: 10.1016/j.cca.2006.01.008. [DOI] [PubMed] [Google Scholar]
  • 10.Wang J, Barke RA, Charboneau R, Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol. 2005;174:426–434. doi: 10.4049/jimmunol.174.1.426. [DOI] [PubMed] [Google Scholar]
  • 11.Sacerdote P, Bianchi M, Gaspani L. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000;90:1411–1414. doi: 10.1097/00000539-200006000-00028. [DOI] [PubMed] [Google Scholar]
  • 12.Jessop DS. Endomorphins as agents for the treatment of chronic inflammatory disease. BioDrugs. 2006;20:161–166. doi: 10.2165/00063030-200620030-00003. [DOI] [PubMed] [Google Scholar]
  • 13.Molina PE. Opioids and opiates: Analgesia with cardiovascular, haemodynamic and immune implications in critical illness. J Intern Med. 2006;259:138–154. doi: 10.1111/j.1365-2796.2005.01569.x. [DOI] [PubMed] [Google Scholar]
  • 14.Carrigan KA, Nelson CJ, Lysle DT. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology (Berl) 2000;151:299–305. doi: 10.1007/s002130000487. [DOI] [PubMed] [Google Scholar]
  • 15.Horvath G. Endomorphin-1 and endomorphin-2: Pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther. 2000;88:437–463. doi: 10.1016/s0163-7258(00)00100-5. [DOI] [PubMed] [Google Scholar]
  • 16.Sedqi M, Roy S, Ramakrishnan S. Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun. 1995;209:563–574. doi: 10.1006/bbrc.1995.1538. [DOI] [PubMed] [Google Scholar]
  • 17.Schroit AJ, Gallily R. Quantitative in vitro phagocytic rate measurements. J Immunol Methods. 1977;17:123–130. doi: 10.1016/0022-1759(77)90083-7. [DOI] [PubMed] [Google Scholar]
  • 18.Jessop DS, Richards LJ, Harbuz MS. Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation. Ann N Y Acad Sci. 2002;966:456–463. doi: 10.1111/j.1749-6632.2002.tb04247.x. [DOI] [PubMed] [Google Scholar]
  • 19.Inui Y, Azuma Y, Ohura K. Differential alteration of functions of rat peritoneal macrophages responsive to endogenous opioid peptide endomorphin-1. Int Immunopharmacol. 2002;2:1133–1142. doi: 10.1016/s1567-5769(02)00065-6. [DOI] [PubMed] [Google Scholar]
  • 20.Azuma Y, Ohura K. Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages. Inflammation. 2002;26:223–232. doi: 10.1023/a:1019766602138. [DOI] [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES